Insulin Aspart (Vials) (Fiasp) and Remifentanil Intravenous
Determining the interaction of Insulin Aspart (Vials) (Fiasp) and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart (Vials) (Fiasp)-Reminyl
- Insulin Aspart (Vials) (Fiasp)-Reminyl ER
- Insulin Aspart (Vials) (Fiasp)-Remodulin
- Insulin Aspart (Vials) (Fiasp)-Remodulin injection
- Insulin Aspart (Vials) (Fiasp)-Remular-S
- Insulin Aspart (Vials) (Fiasp)-Renacidin
- Remifentanil Intravenous-Insulin aspart and insulin aspart protamine
- Remifentanil Intravenous-Insulin aspart and insulin degludec Subcutaneous
- Remifentanil Intravenous-Insulin Aspart Injection
- Remifentanil Intravenous-Insulin Aspart Protamine and Insulin Aspart
- Remifentanil Intravenous-Insulin aspart protamine and insulin aspart Subcutaneous
- Remifentanil Intravenous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)